NCT02230943

Brief Summary

The RISE Registry is an enhanced version of the ACR's Rheumatology Clinical Registry (RCR) and allows for a simplified entry process, while establishing a best-in-class resource to manage your patient population and improve patient care. RISE provides participants with an infrastructure for robust quality improvement activities leading to improved patient outcomes, patient population management and quality reporting related to rheumatic diseases and drug safety. RISE gives physicians and researchers the information they need to optimize patient outcomes, meet reporting requirements, and make discoveries that advance rheumatology.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
100,000

participants targeted

Target at P75+ for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2014

Completed
5 months until next milestone

First Submitted

Initial submission to the registry

August 29, 2014

Completed
5 days until next milestone

First Posted

Study publicly available on registry

September 3, 2014

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2015

Completed
Last Updated

September 3, 2014

Status Verified

August 1, 2014

Enrollment Period

1.7 years

First QC Date

August 29, 2014

Last Update Submit

August 29, 2014

Conditions

Rheumatoid ArthritisOsteoarthritisGout

Keywords

rheumatoidarthritisosteoarthritisgout

Outcome Measures

Primary Outcomes (1)

  • Controlling High Blood Pressure

    Percentage of patients 18-85 years of age who had a diagnosis of hypertension and whose blood pressure was adequately controlled (\<140/90mmHg) during the measurement period.

    one year

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

Primary care clinic

You may qualify if:

  • Patients 18 years of age and older with one of the following diagnoses: rheumatoid arthritis, osteoarthritis, gout

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

American College of Rheumatology

Atlanta, Georgia, 30319, United States

RECRUITING

MeSH Terms

Conditions

Arthritis, RheumatoidOsteoarthritisGoutArthritis

Condition Hierarchy (Ancestors)

Joint DiseasesMusculoskeletal DiseasesRheumatic DiseasesConnective Tissue DiseasesSkin and Connective Tissue DiseasesAutoimmune DiseasesImmune System DiseasesCrystal ArthropathiesPurine-Pyrimidine Metabolism, Inborn ErrorsMetabolism, Inborn ErrorsGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesMetabolic DiseasesNutritional and Metabolic Diseases

Central Study Contacts

Melissa D Francisco

CONTACT

404-633-3777mfrancisco@rheumatology.org

Rachel Myslinski, MBA

CONTACT

404-633-3777rmyslinski@rheumatology.org

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
1 Year
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 29, 2014

First Posted

September 3, 2014

Study Start

April 1, 2014

Primary Completion

December 1, 2015

Last Updated

September 3, 2014

Record last verified: 2014-08

Locations

US(1)